Skip to the page

Data / Federal awards / NAICS 325412 / QUVA PHARMA, INC.

QUVA PHARMA, INC.: 9 federal contract awards, $376,326 obligated (FY2024 to FY2027)

QUVA PHARMA, INC. (UEI MUABDCZXMLG4), Sugar Land, TX, received 9 federal prime contract awards with $376,326 obligated in fiscal years 2024 to 2027, from 2 agencies under 1 NAICS code. Its largest buyer is Department of Health and Human Services ($423,682) and its largest code is NAICS 325412 Pharmaceutical Preparation Manufacturing.

SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.

UEI
MUABDCZXMLG4
Parent organization
QUVA PHARMA INC.
Location
Sugar Land, TX
Business size
Other Than Small Business
Contract awards
9
Obligated
$376,326
First action in window
2023-11-09
Latest action
2026-05-29

Where the work is

NAICS codes, with the other winners in each.

NAICSIndustryAwardsObligated
325412Pharmaceutical Preparation Manufacturing9$376,326

Buying agencies

AgencyAwardsObligated
Department of Health and Human Services8$423,682
Department of Defense1$-47,356

Obligations by fiscal year

Fiscal yearObligated
FY2024$405,434
FY2025$-84,778
FY2026$55,670

Contract awards

All 9 awards in fiscal years 2024 to 2027.

Award IDAgencyTypeNAICSWhat it buysObligated in windowAward valueStartsEndsPlace of performanceSource
75N90024F00001Department of Health and Human ServicesDelivery Order325412OUTSOURCING PCAS AND EPIDURALS$250,000$250,000April 22, 2024September 30, 2024Sugar Land, TXusaspending.gov
75N98026P00592Department of Health and Human ServicesPurchase Order325412OUTSOURCING PCAS AND EPIDURALS FOR PATIENTS CARE FROM QUVA PHARMA, INC.$110,000$110,000May 26, 2026May 25, 2027Bethesda, MDusaspending.gov
75N90025P00194Department of Health and Human ServicesPurchase Order325412PHARMACEUTICALS QUVA PHARMA, INC.:1327585 [25-000116]$100,000$100,000February 19, 2025February 18, 2026Sugar Land, TXusaspending.gov
75N90025P00053Department of Health and Human ServicesPurchase Order325412IV MEDICATIONS QUVA PHARMA, INC.:1327585 [25-000665]$25,000$25,000October 29, 2024September 30, 2025Sugar Land, TXusaspending.gov
75N90019D00030Department of Health and Human ServicesIDC325412STERILE COMPOUNDING 503B FACILITY QUVA PHARMA, INC.:1327585$0$1,500,000September 27, 2019usaspending.gov
75N90025D00001Department of Health and Human ServicesIDC325412NON PATIENT-SPECIFIC STERILE COMPOUNDED PHARMACEUTICAL PRODUCTS FOR PATIENTS IN THE NIH CC ON AN AS CALLED IN BASIS.$0$250,000December 4, 2024usaspending.gov
75N90019F00043Department of Health and Human ServicesDelivery Order325412QUVA PHARMA, INC.:1327585 [19-017387]$-6,988$4,529September 30, 2019September 26, 2020Sugar Land, TXusaspending.gov
W81K0019P0334Department of DefensePurchase Order325412ROPIVACAINE 0.2% IN SODIUM CHLORIDE PF$-47,356$442,636October 1, 2019September 30, 2024Sugar Land, TXusaspending.gov
75N90020F00001Department of Health and Human ServicesDelivery Order325412QUVA PHARMA, INC.:1327585 [POTS: 20-001401]$-54,330$45,670March 6, 2020October 31, 2020Sugar Land, TXusaspending.gov

Also on SpecStream

Updated October 6, 2026. Read from USAspending.gov. Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.